Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study

Lancet

Volumn 358, Issue 9291, 2001, Pages 1405-1409

  Ellervik, Christina ^a   Mandrup Poulsen, Thomas ^b   Nordestgaard, Børge G ^a,c   Larsen, Lisbeth Enggaard ^a   Appleyard, Merete ^c   Frandsen, Merete ^b   Petersen, Pia ^a   Schlichting, Poul ^a   Saermark, Torben ^a   Tybjaerg Hansen, Anne ^c,d   Birgens, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFERRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; LIFE EXPECTANCY; MALE; MASS SCREENING; MUTATION; PREVALENCE; PRIORITY JOURNAL;

EID: 0035960427     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06526-6     Document Type: Article

References (29)

1. Hereditary haemochromatosis
2. Hereditary hemochromatosis. Phenotypic expression of the disease
3. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
4. Long-term survival in patients with hereditary hemochromatosis
5. Long term results of venesection therapy in idiopathic haemochromatosis
6. The effect of repeated phlebotomies in hemochromatosis
7. Management of hereditary hemochromatosis
8. Population screening for hereditary hemochromatosis
9. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
10. Expression of hemochromatosis in homozygous subjects: Implications for early diagnosis and prevention
11. Global prevalence of putative haemochromatosis mutations
12. A population-based study of the clinical expression of the hemochromatosis gene
13. The Copenhagen City Heart Study: Østerbroundersøgelsen - A book of tables with data from the first examination (1976-1978) and a five year follow-up (1981-1983): The Copenhagen City Heart Study Group
14. Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary hemochromatosis
15. Hepatic pathology in relatives of patients with haemochromatosis
16. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: Prospective cohort study
17. Clinical characteristics of type 2 diabetes in patients with mutations of HFE
18. Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes
19. Health care expenditures for people with diabetes mellitus
20. Neonatal screening for the hemochromatosis defect
21. Hemochromatosis: An Irish disease
22. Clinical expression of the hemochromatosis genotype Cys282Tyr in the Busselton population
23. Automated measurement of unsaturated iron binding capacity allows a cost effective ongoing strategy for screening for haemochromatosis
24. The significance of hemochromatosis gene mutations in the general population: Implications for screening
25. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation
26. Hemochromatosis after gene discovery: Revisiting the diagnostic strategy
27. Diagnosis and management of haemochromatosis since discovery of the HFE gene: A European experience